Pharmaceuticals, Biotechnology and Life Sciences
Safety profile consistent with known toxicities of CAR T therapies CAR T persistence observed in 8/10 evaluable responders at Month…
The study achieved its primary objective of decitabine systemic exposure equivalence between oral ASTX727 and IV decitabine with an oral/IV…
Early evidence of clinical activity and robust safety findings highlighted SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Amphivena Therapeutics, Inc., a private clinical…
Company initiates Phase 1 clinical trial of Voriconazole Inhalation Powder, to treat invasive pulmonary aspergillosis (IPA) Successfully completes $24 million…
Updated data from the Phase 3 ALCYONE study demonstrated an overall survival benefit and continued improvement in progression-free survival after…
Initial results from phase 2 study evaluating an investigational use of luspatercept-aamt in myelofibrosis-associated anemia showed promising clinical activity –…
More than four years of durable transfusion independence (TI), stable total hemoglobin (Hb) levels and reduced liver iron concentrations in…
Expanded antibody library expedites the drug discovery process WILMINGTON, Mass. & SAN FRANCISCO–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories International, Inc. (NYSE:…
Researchers also reveal a first-of-its-kind study on long-term health outcomes for bone marrow transplant survivors DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope–City of Hope…
Data Demonstrating Potential in AML and BPDCN Presented During Oral Presentation; Dose and Schedule Selected for Further Development Preclinical Combination…